Successful treatment for a patient with hemophagocytic syndrome after a small-for-size graft liver transplantation.

Published

Journal Article (Academic article)

Hemophagocytic syndrome (HPS) is a hematological disorder caused by activated T lymphocytes, which leads to the proliferation of stimulated macrophages that phagocytose and destroy circulating blood elements and their precursors within bone marrow, and lead to the further production of inflammatory cytokines. Living donor liver transplantation (LDLT) between adults has been performed to compensate for the shortage of available organs. There have been some reports concerning HPS after LDLT; however, its prognosis is disappointingly poor. In particular, there is no report of treated HPS developed after LDLT using small-for-size left lobe grafts. We herein report a case of HPS in a 63-year old woman who underwent LDLT using left lobe graft weighing only 330g. The HPS was diagnosed on postoperative day 13, and was successfully treated using a combination of intravenous immunoglobulin, granulocyte colony stimulating factor, conversion of calcineurin inhibitor and steroid pulse. The trigger of HPS may not only be systemic infection, but also hypercytokinemia caused by various factors. HPS is a fatal complication in immunologically compromised patients; however, early and accurate diagnosis could lead to an adequate treatment and improve the outcome.

Duke Authors

Cited Authors

  • Yoshizumi, T; Taketomi, A; Kayashima, H; Harada, N; Uchiyama, H; Yamashita, Y; Ikegami, T; Soejima, Y; Nishizaki, T; Shimada, M; Maehara, Y

Published Date

  • December 2008

Published In

Volume / Issue

  • 55 / 82-83

Start / End Page

  • 359 - 362

International Standard Serial Number (ISSN)

  • 0172-6390

Language

  • English